Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Intangibles: 2022-2024

  • Eton Pharmaceuticals' Change in Intangibles rose 947.74% to $8.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $12.8 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 1188.77% up from last year.
  • According to the latest figures from Q4 2024, Eton Pharmaceuticals' Change in Intangibles is $8.1 million, which was up 334.69% from $1.9 million recorded in Q1 2024.
  • Eton Pharmaceuticals' Change in Intangibles' 5-year high stood at $8.1 million during Q4 2024, with a 5-year trough of $775,000 in Q4 2023.
  • For the 3-year period, Eton Pharmaceuticals' Change in Intangibles averaged around $3.2 million, with its median value being $1.9 million (2022).
  • Data for Eton Pharmaceuticals' Change in Intangibles shows a peak YoY spiked of 947.74% (in 2024) over the last 5 years.
  • Over the past 3 years, Eton Pharmaceuticals' Change in Intangibles (Quarterly) stood at $2.0 million in 2022, then reached $775,000 in 2023, then spiked by 947.74% to $8.1 million in 2024.
  • Its last three reported values are $8.1 million in Q4 2024, $1.9 million for Q1 2024, and $775,000 during Q4 2023.